# Akyva First In Human

> **NCT06956209** · NA · RECRUITING · sponsor: **Iota Biosciences, Inc** · enrollment: 15 (estimated)

## Conditions studied

- Underactive Bladder

## Interventions

- **DEVICE:** Direct Bladder Wall Stimulation

## Key facts

- **NCT ID:** NCT06956209
- **Lead sponsor:** Iota Biosciences, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-24
- **Primary completion:** 2028-09
- **Final completion:** 2028-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06956209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06956209, "Akyva First In Human". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06956209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*